392 related articles for article (PubMed ID: 18186265)
1. [Adjuvant chemotherapy for resectable non-small cell lung cancer (NSCLC)].
Nakajima E; Katou H
Kyobu Geka; 2008 Jan; 61(1):4-8. PubMed ID: 18186265
[TBL] [Abstract][Full Text] [Related]
2. Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.
Johnson BE; Rabin MS
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5022s-5026s. PubMed ID: 16000607
[TBL] [Abstract][Full Text] [Related]
3. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.
Pisters KM; Evans WK; Azzoli CG; Kris MG; Smith CA; Desch CE; Somerfield MR; Brouwers MC; Darling G; Ellis PM; Gaspar LE; Pass HI; Spigel DR; Strawn JR; Ung YC; Shepherd FA; ;
J Clin Oncol; 2007 Dec; 25(34):5506-18. PubMed ID: 17954710
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for non-small cell lung cancer.
Solomon B; Bunn PA
Cancer Invest; 2007 Jun; 25(4):217-25. PubMed ID: 17612931
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy in non-small cell lung cancer.
Le Chevalier T
Semin Oncol; 1998 Aug; 25(4 Suppl 9):62-5. PubMed ID: 9728587
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?
Tiseo M; Franciosi V; Grossi F; Ardizzoni A
Eur J Cancer; 2006 Jan; 42(1):8-16. PubMed ID: 16293409
[TBL] [Abstract][Full Text] [Related]
7. Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease.
Wakelee H; Dubey S; Gandara D
Oncologist; 2007 Mar; 12(3):331-7. PubMed ID: 17405898
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for non-small cell lung cancer: a New Zealand perspective.
Sasidharan R; Gibbs D; Sullivan R; Simpson A; Perez D; Christmas T; McKeage M
N Z Med J; 2006 Nov; 119(1245):U2310. PubMed ID: 17146485
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?
Geiger S; Schlemmer M; Heinemann V; Stemmler HJ
Anticancer Drugs; 2010 Oct; 21(9):799-804. PubMed ID: 20679887
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
Dunant A; Pignon JP; Le Chevalier T
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5017s-5021s. PubMed ID: 16000606
[TBL] [Abstract][Full Text] [Related]
11. Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
Hoffmann H
Lung Cancer; 2004 Aug; 45 Suppl 2():S91-7. PubMed ID: 15552788
[TBL] [Abstract][Full Text] [Related]
12. [Early stages of non small cell lung cancer (I. II. IIIA). Postoperative treatments for resected non small-cell lung cancer].
Barlési F
Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S47-16S53. PubMed ID: 17268336
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
Tanaka F; Wada H
Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program.
Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E
J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078
[TBL] [Abstract][Full Text] [Related]
16. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.
Douillard JY; Rosell R; De Lena M; Riggi M; Hurteloup P; Mahe MA;
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):695-701. PubMed ID: 18439766
[TBL] [Abstract][Full Text] [Related]
17. Preoperative chemotherapy in early-stage (stage IB-IIIA) resectable non small cell lung cancer. Is it justified?
Prokakis Ch; Koletsis EN; Apostolakis E; Chatzimichalis A; Dougenis D
J BUON; 2008; 13(2):161-8. PubMed ID: 18555460
[TBL] [Abstract][Full Text] [Related]
18. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
[TBL] [Abstract][Full Text] [Related]
19. The ALPI Trial: the Italian/European experience with adjuvant chemotherapy in resectable non-small lung cancer.
Scagliotti GV
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5011s-5016s. PubMed ID: 16000605
[TBL] [Abstract][Full Text] [Related]
20. Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer.
Hotta K; Matsuo K; Kiura K; Ueoka H; Tanimoto M
Curr Opin Oncol; 2006 Mar; 18(2):144-50. PubMed ID: 16462183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
